Citations (7)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Halit Diri, Sulbiye Karaburgu, Banu Acmaz, Kursad Unluhizarci, Fatih Tanriverdi, Zuleyha Karaca & Fahrettin Kelestimur. (2016) Comparison of spironolactone and spironolactone plus metformin in the treatment of polycystic ovary syndrome. Gynecological Endocrinology 32:1, pages 42-45.
Read now
Read now
Articles from other publishers (6)
Stephanie E. Areloegbe, Atuma L. Chukwubueze, Adewumi O. Oyabambi & Kehinde S. Olaniyi. (2023) Low-dose spironolactone attenuates metabolic defects in the skeletal muscle of letrozole-induced hyperandrogenic female rats. Nutrire 48:1.
Crossref
Crossref
Tao Long, Ying Zhang, Chunping Zeng, Siyuan Zheng, Lin Zhou & Haiyan Liu. (2022) Effects of Low-Dose Spironolactone Combined with Metformin or Either Drug Alone on Insulin Resistance in Patients with Polycystic Ovary Syndrome: A Pilot Study. International Journal of Endocrinology 2022, pages 1-8.
Crossref
Crossref
Mohd Ashraf Ganie, Subhankar Chowdhury, Vanita Suri, Beena Joshi, Prasanta Kumar Bhattacharya, Sarita Agrawal, Neena Malhotra, Rakesh Sahay, Roya Rozati, Puthiyaveettil Khadar Jabbar, Vishnubhatla Sreenivas, Mukesh Sriwastva, Imtiyaz Ahmad Wani, Shalini Singh & Radhey Shyam Sharma. (2021) Evaluation of the Prevalence, Regional Phenotypic Variation, Comorbidities, Risk Factors, and Variations in Response to Different Therapeutic Modalities Among Indian Women: Proposal for the Indian Council of Medical Research–Polycystic Ovary Syndrome (ICMR–PCOS) Study. JMIR Research Protocols 10:8, pages e23437.
Crossref
Crossref
Oluwaseun A. Adeyanju, Timothy O. Falodun, Oyesanmi A. Fabunmi, Lawrence A. Olatunji & Ayodele O. Soladoye. (2019) Very low dose spironolactone protects experimentally-induced polycystic ovarian syndrome from insulin-resistant metabolic disturbances by suppressing elevated circulating testosterone. Chemico-Biological Interactions 310, pages 108742.
Crossref
Crossref
MohammadAshraf Ganie, Vishnu Vasudevan, ImtiyazAhmad Wani, MohammadSalem Baba, Tasleem Arif & Aafia Rashid. (2019) Epidemiology, pathogenesis, genetics & management of polycystic ovary syndrome in India. Indian Journal of Medical Research 150:4, pages 333.
Crossref
Crossref
Sandra Korol, Fannie Mottet, Sylvie Perreault, William L. Baker, Michel White & Simon de Denus. (2017) A systematic review and meta-analysis of the impact of mineralocorticoid receptor antagonists on glucose homeostasis. Medicine 96:48, pages e8719.
Crossref
Crossref